|4. Treat with an OSM over an IL-17i biologic (PICO 12)|Very low|
|Conditional recommendation based on very-low-quality evidence; may consider an IL-17i biologic if the patient has severe psoriasis and/or severe PsA.| |
|5. Treat with an OSM over an IL-12/23i biologic (PICO 11)|Very low|